Cargando…
IL-17A increases MHC class I expression and promotes T cell activation in papillary thyroid cancer patients with coexistent Hashimoto’s thyroiditis
BACKGROUND: The incidence of coexisting papillary thyroid cancer (PTC) and Hashimoto’s thyroiditis (HT) is increasing. The impact of HT on PTC prognosis and its possible mechanism remains controversial. Interleukin-17A (IL-17A) has been reported to participate in the pathogenesis of multiple autoimm...
Autores principales: | Han, Li-Tao, Hu, Jia-Qian, Ma, Ben, Wen, Duo, Zhang, Ting-Ting, Lu, Zhong-Wu, Wei, Wen-Jun, Wang, Yu-Long, WANG, Yu, Liao, Tian, Ji, Qing-Hai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6547553/ https://www.ncbi.nlm.nih.gov/pubmed/31159823 http://dx.doi.org/10.1186/s13000-019-0832-2 |
Ejemplares similares
-
IL-2 enhanced MHC class I expression in papillary thyroid cancer with Hashimoto's thyroiditis overcomes immune escape in vitro
por: Hu, Jia-Qian, et al.
Publicado: (2020) -
IL-10 Restores MHC Class I Expression and Interferes With Immunity in Papillary Thyroid Cancer With Hashimoto Thyroiditis
por: Lu, Zhong-Wu, et al.
Publicado: (2020) -
Coexistence of papillary thyroid cancer with Hashimoto thyroiditis
por: Konturek, Aleksander, et al.
Publicado: (2012) -
Genetic relationship between Hashimoto`s thyroiditis and papillary thyroid carcinoma with coexisting Hashimoto`s thyroiditis
por: Subhi, Ohoud, et al.
Publicado: (2020) -
Clinical analysis of Hashimoto thyroiditis coexistent
with papillary thyroid cancer in 1392 patients
por: Liang, J., et al.
Publicado: (2017)